SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-119372
Filing Date
2021-09-24
Accepted
2021-09-24 17:15:46
Documents
15
Period of Report
2021-09-20
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2128334-1_8k.htm   iXBRL 8-K 28348
2 EXHIBIT 16.1 tm2128334d1_ex16-1.htm EX-16.1 3836
6 GRAPHIC image_001.gif GRAPHIC 1805
7 GRAPHIC image_001.jpg GRAPHIC 1936
  Complete submission text file 0001104659-21-119372.txt   213303

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbio-20210920.xsd EX-101.SCH 3195
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20210920_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20210920_pre.xml EX-101.PRE 22717
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2128334-1_8k_htm.xml XML 3600
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 211278234
SIC: 2834 Pharmaceutical Preparations